ACE and hypertensive disorder: A total of 18% of patients were treated with cardioprotective therapies, such as angiotensin‐converting enzyme inhibitors (ACE‐I), angiotensin II receptor blockers (ARB), or beta‐blockers, mainly indicated for HTN.